|
Auranofin |
|
Clostridium |
CDT (Clostridium difficile toxin) |
Preclinical (in vivo) |
AbdelKhalek A, et al. 2019. Int J Antimicrob Agents; Hutton ML, et al. 2020. J Antimicrob Chemother; Abutaleb NS, et al. 2020. Sci Rep |
|
(2R,3R)-2-[[3-(2-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
CH
3
O
O
S
N
H
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(2,4-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(2,5-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(2,6-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(2-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(3,4-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(3-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
Cl
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(furan-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
O
H
3
C
O
O
S
N
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(furan-3-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
O
H
3
C
O
O
S
N
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
| | |